C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

How City of Hope is using AI to improve surgical outcomes

With recent leaps in artificial intelligence, there is major potential to turn computing advances into gains for human health.

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

University Hospitals Cleveland Medical Center has announced a collaboration with global healthcare AI company Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.

April 04, 2025

Vol.51 No.13

In Brief

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Paradigm Health announced on March 20 the appointment of Karen E. Knudsen to its board of directors, alongside the upcoming launch of its eSource clinical trial data application.

March 28, 2025

Vol.51 No.12

Guest Editorial

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.

March 21, 2025

Vol.51 No.11

By Jamillah Hoy-Rosas

In Brief

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

After serving as the director of the National Human Genome Research Institute for more than 15 years, Eric Green has left his role.

March 21, 2025

Vol.51 No.11

Clinical Roundup

AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows

A study led by UCLA investigators shows that AI could play a key role in improving treatment outcomes for patients with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

March 21, 2025

Vol.51 No.11

C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

YOU MAY BE INTERESTED IN

How City of Hope is using AI to improve surgical outcomes

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows

Renew today!

Subscriber content

Never miss an issue!

Login